Major R&D Pipeline: 3ADCs

DS-3201 ATL/PTCL development plan Clinical studies for ATL/PTCL Region NHL Ph1 study ATL, PTCL and others (NCT02732275/JapicCTI-163173) US/JP R/R ATL Registrational Ph2 study JP (NCT04102150/JapicCTI-194964) R/R PTCL Registrational Ph2 study Global VALENTINE-PTCL01 (NCT04703192/jRCT2071200095) Status Presented interim data at EHA 2021 Obtained TLR in July ➤ Preparation underway for filing in Japan in FY2021 2H First patient dosed in June. SAKIGAKE designation in Japan ATL: adult T-cell leukemia/lymphoma, EHA: European Hematology Association, NHL: non Hodgkin's lymphoma, PTCL: peripheral T-cell lymphoma, R/R: relapsed/refractory, TLR: top line results Daiichi-Sankyo 26

View entire presentation